Oncology Pharma Inc. (ONPH)
OTCMKTS
· Delayed Price · Currency is USD
0.0103
0.00 (0.00%)
At close: Mar 5, 2026
Oncology Pharma Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2013 | FY 2011 | FY 2004 | FY 2003 | FY 2002 | 2001 - 1997 |
|---|---|---|---|---|---|---|
Period Ending | Mar '13 Mar 31, 2013 | Jun '11 Jun 30, 2011 | Mar '04 Mar 31, 2004 | Mar '03 Mar 31, 2003 | Mar '02 Mar 31, 2002 | 2001 - 1997 |
| Cash & Equivalents | 0.01 | - | 0.01 | 1.35 | 2.93 | Upgrade
|
| Cash & Short-Term Investments | 0.01 | - | 0.01 | 1.35 | 2.93 | Upgrade
|
| Cash Growth | - | - | -99.41% | -54.12% | -28.02% | Upgrade
|
| Accounts Receivable | - | - | 0.02 | 0.17 | 0.06 | Upgrade
|
| Receivables | - | 0.02 | 0.02 | 0.17 | 0.06 | Upgrade
|
| Inventory | 0.18 | 0.15 | - | - | - | Upgrade
|
| Other Current Assets | - | - | 0.02 | 0.06 | 0.11 | Upgrade
|
| Total Current Assets | 0.19 | 0.17 | 0.05 | 1.58 | 3.1 | Upgrade
|
| Property, Plant & Equipment | 0.01 | 0.06 | - | 0.13 | 0.5 | Upgrade
|
| Other Intangible Assets | 0.01 | 0.04 | - | - | - | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.05 | 0.01 | Upgrade
|
| Total Assets | 0.2 | 0.26 | 0.05 | 1.75 | 3.61 | Upgrade
|
| Accounts Payable | 0.01 | 0.01 | 0.01 | 0.27 | 0.17 | Upgrade
|
| Accrued Expenses | - | - | 0.18 | 0.46 | 0.74 | Upgrade
|
| Short-Term Debt | 0.21 | 0.66 | 0.03 | - | - | Upgrade
|
| Current Income Taxes Payable | 0 | - | - | - | - | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.15 | 0.33 | Upgrade
|
| Total Current Liabilities | 0.21 | 0.67 | 0.22 | 0.88 | 1.24 | Upgrade
|
| Long-Term Debt | 0.21 | - | - | - | - | Upgrade
|
| Total Liabilities | 0.42 | 0.67 | 0.22 | 0.88 | 1.24 | Upgrade
|
| Common Stock | 0.41 | 0.07 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 25.4 | 25.38 | 25.38 | 24.87 | 24.76 | Upgrade
|
| Retained Earnings | -26.03 | -25.86 | -25.57 | -24 | -22.48 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | 0.09 | Upgrade
|
| Total Common Equity | -0.22 | -0.41 | -0.17 | 0.87 | 2.37 | Upgrade
|
| Shareholders' Equity | -0.22 | -0.4 | -0.17 | 0.87 | 2.37 | Upgrade
|
| Total Liabilities & Equity | 0.2 | 0.26 | 0.05 | 1.75 | 3.61 | Upgrade
|
| Total Debt | 0.41 | 0.66 | 0.03 | - | - | Upgrade
|
| Net Cash (Debt) | -0.4 | -0.66 | -0.02 | 1.35 | 2.93 | Upgrade
|
| Net Cash Growth | - | - | - | -54.12% | -28.02% | Upgrade
|
| Working Capital | -0.03 | -0.5 | -0.17 | 0.7 | 1.86 | Upgrade
|
| Tangible Book Value | -0.23 | -0.44 | -0.17 | 0.87 | 2.37 | Upgrade
|
| Buildings | - | - | - | 0.04 | 0.04 | Upgrade
|
| Machinery | - | - | - | 0.79 | 1.18 | Upgrade
|
| Leasehold Improvements | - | - | - | 0.04 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.